Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...
ScienceAlert on MSN
Forever Chemicals Linked to Multiple Sclerosis in Concerning New Study
People who are exposed to certain forever chemicals may be at greater risk of developing multiple sclerosis (MS), according ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational medicine ocrelizumab (OCREVUSTM ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
The National on MSN
Could stem cell treatments bring about MS breakthrough?
UAE recently used stem cell therapy for disease for first time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results